Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.

Ramanathan S, Johnson S, Burns SP, Kralovic SM, Goldstein B, Smith B, Gerding DN, Evans CT.

Am J Infect Control. 2014 Feb;42(2):168-73. doi: 10.1016/j.ajic.2013.08.009.

PMID:
24485372
2.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ.

Clin Infect Dis. 2007 Nov 1;45(9):1141-51. Epub 2007 Sep 26.

PMID:
17918075
3.

Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.

Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE.

Anaerobe. 2014 Dec;30:65-9. doi: 10.1016/j.anaerobe.2014.08.015. Epub 2014 Sep 8.

PMID:
25219941
4.

Community-associated Clostridium difficile infection among veterans with spinal cord injury and disorder.

Balbale SN, Johnson S, Burns SP, Kralovic SM, Goldstein B, Gerding DN, Evans CT.

Infect Control Hosp Epidemiol. 2014 May;35(5):577-80. doi: 10.1086/675830. Epub 2014 Mar 24.

5.

Clinical predictors of recurrent Clostridium difficile infection in out-patients.

Shivashankar R, Khanna S, Kammer PP, Scott Harmsen W, Zinsmeister AR, Baddour LM, Pardi DS.

Aliment Pharmacol Ther. 2014 Sep;40(5):518-22. doi: 10.1111/apt.12864. Epub 2014 Jul 10.

6.

Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.

Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL.

World J Gastroenterol. 2015 Jun 7;21(21):6728-35. doi: 10.3748/wjg.v21.i21.6728.

7.

Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.

Gordon D, Young LR, Reddy S, Bergman C, Young JD.

J Hosp Infect. 2016 Feb;92(2):173-7. doi: 10.1016/j.jhin.2015.10.009. Epub 2015 Nov 2.

PMID:
26616410
8.

Predictors of first recurrence of Clostridium difficile infections in children.

Tschudin-Sutter S, Tamma PD, Milstone AM, Perl TM.

Pediatr Infect Dis J. 2014 Apr;33(4):414-6. doi: 10.1097/INF.0000000000000108.

PMID:
24168983
9.

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.

Pakyz AL, Jawahar R, Wang Q, Harpe SE.

J Antimicrob Chemother. 2014 Apr;69(4):1127-31. doi: 10.1093/jac/dkt489. Epub 2013 Dec 9.

PMID:
24327619
10.

Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.

Han XH, Du CX, Zhang CL, Zheng CL, Wang L, Li D, Feng Y, DuPont HL, Jiang ZD, Shi YK.

Anaerobe. 2013 Dec;24:82-4. doi: 10.1016/j.anaerobe.2013.05.004. Epub 2013 Jun 14.

PMID:
23770543
11.

Recurrent Clostridium difficile infection is associated with increased mortality.

Olsen MA, Yan Y, Reske KA, Zilberberg MD, Dubberke ER.

Clin Microbiol Infect. 2015 Feb;21(2):164-70. doi: 10.1016/j.cmi.2014.08.017. Epub 2014 Oct 12.

12.

Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness.

Kim JH, Toy D, Muder RR.

Infect Control Hosp Epidemiol. 2011 Jul;32(7):656-60. doi: 10.1086/660767.

PMID:
21666395
13.

The evaluation of Clostridium difficile infection (CDI) in a community hospital.

Daniel A, Rapose A.

J Infect Public Health. 2015 Mar-Apr;8(2):155-60. doi: 10.1016/j.jiph.2014.08.002. Epub 2014 Oct 6.

14.

Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes.

Haines CF, Moore RD, Bartlett JG, Sears CL, Cosgrove SE, Carroll K, Gebo KA.

AIDS. 2013 Nov 13;27(17):2799-807. doi: 10.1097/01.aids.0000432450.37863.e9.

15.

The prolongation of length of stay because of Clostridium difficile infection.

Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N.

Am J Infect Control. 2014 Feb;42(2):164-7. doi: 10.1016/j.ajic.2013.07.006. Epub 2013 Dec 2.

PMID:
24290226
16.

Clostridium difficile infection in children hospitalized due to diarrhea.

Dulęba K, Pawłowska M, Wietlicka-Piszcz M.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):201-9. doi: 10.1007/s10096-013-1946-1. Epub 2013 Nov 10.

17.

Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.

Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.

Pharmacotherapy. 2012 Aug;32(8):744-54. doi: 10.1002/j.1875-9114.2012.01160.x.

PMID:
23307522
18.

Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.

Marufu O, Desai N, Aldred D, Brown T, Eltringham I.

J Hosp Infect. 2015 Jan;89(1):38-45. doi: 10.1016/j.jhin.2014.10.003. Epub 2014 Oct 24.

PMID:
25480022
19.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA.

Arch Intern Med. 2010 May 10;170(9):772-8. doi: 10.1001/archinternmed.2010.73. Erratum in: Arch Intern Med. 2010 Jul 12;170(13):1100.

PMID:
20458084
20.

The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010.

Reveles KR, Lee GC, Boyd NK, Frei CR.

Am J Infect Control. 2014 Oct;42(10):1028-32. doi: 10.1016/j.ajic.2014.06.011.

PMID:
25278388

Supplemental Content

Support Center